-
Former Grand Slam winner Wawrinka ends tennis career
-
Last-gasp Sabitzer strike sends Dortmund past Bremen in German Cup
-
Brazil's Flavio Bolsonaro flees to US after election loss
-
Rights groups reject Emirati diplomat for UN top job
-
'Faerie' nights: 'ACOTAR' fans finally get their book
-
Flavio Bolsonaro headed to US after Brazil election defeat: US media
-
American woman convicted of getting military training from Islamic State
-
Alcaraz and Zverev win Vienna openers
-
Israel opposition holds narrow edge over Netanyahu in first projections
-
Tech firms gain ahead of Fed decision, results from AI giants
-
Floriani hits maiden goal as Lazio go top
-
Syria condemns deadly Jordan strikes as 'unacceptable violation'
-
Trump set to drastically loosen oil and gas sector's methane rules
-
England's Fin Smith in race against time to face Australia
-
Storied Paris department store seeks bankruptcy protection
-
UN nuclear watchdog chief urges Iran to grant access
-
Xhaka, Embolo can return to Swiss squad after fake Covid docs affair
-
Boeing shares tumble after it releases cautious growth forecast
-
Allegri suspended for two Serie A games after red card
-
Lula's re-election revives Brazil-US tensions
-
Flight data, satellite images reveal growing US role at Ecuador base
-
Carney moves to remake Canada alliances as US ties strained
-
McInnes feels 'guilt' ahead of Hearts return with Rangers
-
Serbia's students demand state media chiefs resign after poll win
-
Brazil's Lula turns 81, vows to work '24 hours a day'
-
Starc takes six as Australia fight back in South Africa decider
-
Boeing releases cautious growth plan as shares fall sharply
-
UK man offered drugged wife to strangers online for sex: court
-
Exiled Russian dissident Navalnaya warns dictators becoming 'more cunning'
-
Africa Ebola outbreak passes 10,000 cases, mostly in DR Congo
-
Bayern 'risk' reaps huge reward for Ballon d'Or winner Kane
-
EU pushes for more nations to pay to protect nature
-
Record turnout as Israeli voters deliver verdict on Netanyahu
-
Boeing reports smaller loss as it aims for stable output growth
-
Iraola says Isak 'feels the trust' after Liverpool scoring streak
-
Tech firms gain on Anthropic IPO optimism; HSBC slumps in London
-
French media protest manhandling of journalists at far-right party rally
-
Sri Lanka end England hopes with crushing win over Pakistan
-
EU seeks deportation powers for beefed up border agency
-
Dangote, Nigeria's oil tycoon rewriting Africa's story
-
Two charged with UK security offences over airbase plot: police
-
Carrick to remain Man Utd boss for Chelsea clash: reports
-
Maresca defends Donnarumma, Guehi after Man City defeat
-
Greenhouse gas levels hit new record highs in 2025: UN
-
Nordic leaders call Putin as local truce begins in Ukraine
-
Rybakina looking to clinch year-end number one in Tokyo
-
Osaka unveils crane outfit in Tokyo before win over Paolini
-
Tech firms track Wall St rally on mixed day for stock markets
-
Ronaldo in line for Portugal return after fallout with coach
-
Kane says Ballon d'Or win 'feels like a dream' as tributes pour in
'Pharma Bro' Shkreli released to halfway house in US
So-called "Pharma bro" Martin Shkreli has been released from a Pennsylvania prison to a halfway house in New York state, the US Bureau of Prisons said Wednesday.
Shkreli, who became a poster child for predatory pharmaceutical pricing before being convicted of securities fraud in 2017, was transferred Wednesday from a low-security prison in Allenwood, Pennsylvania to undisclosed "community confinement" in New York state, said a BOP spokesperson in an email.
He is scheduled to be released from BOP's custody on September 14, the spokesperson said.
Shkreli's attorney, Benjamin Brafman, confirmed the release, saying he was "pleased" to report that his client was let out early "after completing all programs that allowed for his prison sentence to be shortened," according to a statement.
"While in the halfway house I have encouraged Mr. Shkreli to make no further statement, nor will he or I have any additional comments at this time."
Once dubbed "the most hated man in America," Shkreli, 39, became infamous for suddenly raising the price of the HIV drug Daraprim in 2015 by 5,000 percent -- from $13.50 a pill to $750.
Shkreli was originally sentenced in 2018 to seven years in prison in a fraud case not directly related to the Daraprim matter. He has been in custody since September 2017.
L.Dubois--BTB